Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04503759 · ClinicalTrials.gov registry record
Artoss Foot and Ankle Surgery Registry
A clinical trial, sponsored by Artoss.
- Completed
- Registry status
- 200
- Enrollment target
NCT04503759: Completed study, sponsored by Artoss.
NCT04503759 is a clinical trial that has completed, run by Artoss. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04503759 has completed, sponsored by Artoss.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
This prospective registry was designed as an observational study to ascertain how commercially available NanoBone products are being used by surgeons performing foot and ankle surgery which involves bone grafting, as well as determining relevant patient outcomes.
Primary Outcome
Fusion/Graft Consolidation: Evidence of bony (osseous) bridging between the graft material and the patient's bone in the segment requiring fusion or reconstruction.
Interventions
- OTHER NanoBone Bone Graft Substitute
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2024-05-10 |
What the finished NCT04503759 record still lists
NCT04503759 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which NanoBone Bone Graft Substitute is the first listed.
NCT04503759 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04503759 about?
NCT04503759 is a clinical study titled "Artoss Foot and Ankle Surgery Registry". This prospective registry was designed as an observational study to ascertain how commercially available NanoBone products are being used by surgeons performing foot and ankle surgery which involves bone grafting, as well as determining relevant patient outcomes.
What is the current status of trial NCT04503759?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2020-08-01. Estimated completion is 2024-05-10.
What interventions are being tested in trial NCT04503759?
The interventions under investigation include: NanoBone Bone Graft Substitute (OTHER).
Who is sponsoring clinical trial NCT04503759?
This trial is sponsored by Artoss, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI